FibroBiologics, Inc. Common Stock (FBLG) vs Jaguar Health, Inc. (JAGX)
A side-by-side comparison of FibroBiologics, Inc. Common Stock and Jaguar Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FBLG
FibroBiologics, Inc. Common Stock
$1.16HealthcareDelayed quote: Oct 6, 2026, 10:00 AM EDT
JAGX
Jaguar Health, Inc.
$6.54HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
Total return — FBLG vs JAGX
growth of $100 · dividends reinvested · last 1yFBLG -97.5% (-97.5%/yr)JAGX -83.3% (-83.3%/yr)JAGX compounded faster over this window
Log scale — wide-divergence pair
FBLG JAGX
FBLG vs JAGX: by the numbers
- •JAGX is the larger company ($3M vs $2M market cap).
- •Both run net losses; FBLG's is the smaller (0.00% vs -131.76% net margin).
Metrics side by side
Valuation
| Metric | FBLG | JAGX |
|---|---|---|
| P/S ratio | N/A | 0.10 |
| P/B ratio | 0.52 | 0.43 |
Profitability
| Metric | FBLG | JAGX |
|---|---|---|
| Gross margin | 0.00% | 67.21% |
| Operating margin | 0.00% | -391.87% |
| Net margin | 0.00% | -131.76% |
| ROE | -391.26% | -554.01% |
| ROIC | -286.46% | -110.81% |
Growth (annualized)
| Metric | FBLG | JAGX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 31.88% |
Go deeper
Dig into the metrics
FibroBiologics, Inc. Common Stock ROEJaguar Health ROEFibroBiologics, Inc. Common Stock operating marginJaguar Health operating marginFibroBiologics, Inc. Common Stock revenue growthJaguar Health revenue growthFibroBiologics, Inc. Common Stock free cash flowJaguar Health free cash flow
FibroBiologics, Inc. Common Stock & Jaguar Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.